Aspell T, Khemlani A, Tsai C, Loh J, Proft T
Microorganisms. 2023; 11(2).
PMID: 36838272
PMC: 9966966.
DOI: 10.3390/microorganisms11020305.
Kim J, Bayo J, Cha J, Choi Y, Jung M, Kim D
PLoS One. 2019; 14(6):e0218922.
PMID: 31242260
PMC: 6594638.
DOI: 10.1371/journal.pone.0218922.
Yoon J, Cho H, Park C, Park B, Kim Y, Min J
Curr Microbiol. 2016; 74(1):22-27.
PMID: 27757529
DOI: 10.1007/s00284-016-1146-1.
Ginsburg I, Neeman N, Duchan Z, Sela M, James J, Lahav M
Inflammation. 2013; 1(1):41-56.
PMID: 24194401
DOI: 10.1007/BF00918058.
Yoon J, Park J, Jung S, Kim K, Kim Y, Min J
Curr Microbiol. 2009; 59(1):48-52.
PMID: 19319596
DOI: 10.1007/s00284-009-9392-0.
Peptidoglycan O acetylation and autolysin profile of Enterococcus faecalis in the viable but nonculturable state.
Pfeffer J, Strating H, Weadge J, Clarke A
J Bacteriol. 2006; 188(3):902-8.
PMID: 16428393
PMC: 1347352.
DOI: 10.1128/JB.188.3.902-908.2006.
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme.
Fernie-King B, Seilly D, Davies A, Lachmann P
Infect Immun. 2002; 70(9):4908-16.
PMID: 12183536
PMC: 128256.
DOI: 10.1128/IAI.70.9.4908-4916.2002.
Peptidoglycan loss during hen egg white lysozyme-inorganic salt lysis of Streptococcus mutans.
Goodman H, Pollock J, Iacono V, Wong W, SHOCKMAN G
J Bacteriol. 1981; 146(2):755-63.
PMID: 7217016
PMC: 217022.
DOI: 10.1128/jb.146.2.755-763.1981.
Lysis and protoplast formation of group B streptococci by mutanolysin.
Calandra G, Cole R
Infect Immun. 1980; 28(3):1033-7.
PMID: 6995317
PMC: 551054.
DOI: 10.1128/iai.28.3.1033-1037.1980.
Mutanolysin enhancement of serogrouping of single colonies of streptococci.
Calandra G, Henson C
J Clin Microbiol. 1982; 15(1):184-6.
PMID: 6764770
PMC: 272051.
DOI: 10.1128/jcm.15.1.184-186.1982.
Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.
Spitznagel J, Goodrum K, Warejcka D
Am J Pathol. 1983; 112(1):37-47.
PMID: 6407330
PMC: 1916309.
Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes.
ROSENTHAL R, Folkening W, Miller D, Swim S
Infect Immun. 1983; 40(3):903-11.
PMID: 6406367
PMC: 348137.
DOI: 10.1128/iai.40.3.903-911.1983.
Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin.
Janusz M, Chetty C, Eisenberg R, CROMARTIE W, Schwab J
J Exp Med. 1984; 160(5):1360-74.
PMID: 6387033
PMC: 2187511.
DOI: 10.1084/jem.160.5.1360.
Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation.
Leong P, Schwab J, Cohen M
Infect Immun. 1984; 45(1):160-5.
PMID: 6329955
PMC: 263294.
DOI: 10.1128/iai.45.1.160-165.1984.
Electron microscopic studies on streptococci. II. Group A carbohydrate.
Swanson J, Gotschlich E
J Exp Med. 1973; 138(1):245-58.
PMID: 4577619
PMC: 2180534.
DOI: 10.1084/jem.138.1.245.
Influence of protein synthesis inhibitors on regulation of extent of O-acetylation of gonococcal peptidoglycan.
ROSENTHAL R, Gfell M, Folkening W
Infect Immun. 1985; 49(1):7-13.
PMID: 3924833
PMC: 262049.
DOI: 10.1128/iai.49.1.7-13.1985.
In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase.
Jacquot J, Tournier J, Puchelle E
Infect Immun. 1985; 47(2):555-60.
PMID: 3917980
PMC: 263208.
DOI: 10.1128/iai.47.2.555-560.1985.
Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.
Stimpson S, Lerch R, Cleland D, Yarnall D, CLARK R, CROMARTIE W
Infect Immun. 1987; 55(1):16-23.
PMID: 3539800
PMC: 260274.
DOI: 10.1128/iai.55.1.16-23.1987.
In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.
Janusz M, Esser R, Schwab J
Infect Immun. 1986; 52(2):459-67.
PMID: 3516873
PMC: 261021.
DOI: 10.1128/iai.52.2.459-467.1986.
Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.
Spitznagel J, Goodrum K, Warejcka D, Weaver J, Miller H, Babcock L
Infect Immun. 1986; 52(3):803-11.
PMID: 3086232
PMC: 260930.
DOI: 10.1128/iai.52.3.803-811.1986.